You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫渡科技(02158.HK)聯屬公司中標北京回龍觀醫院二期擴建信息化建設項目 項目總金額1250萬元
格隆匯 06-11 12:21

格隆匯6月11日丨醫渡科技(02158.HK)公佈,近期,公司的聯屬公司醫渡雲(北京)技術有限公司中標北京回龍觀醫院二期擴建信息化建設項目,項目總金額約為人民幣1250萬元。

作為中國AI醫療變革驅動者,醫渡科技秉承「使精準醫療惠及每一個人」的使命,打造專業、高效、精準且普惠的醫學人工智能產品與解決方案。基於公司自主研發的核心算法引擎YiduCore,醫渡科技構建「數據—算法—場景」飛輪閉環,實現了AI技術的高效率創新、低成本規模化應用,推動智能決策賦能「醫—藥—險—患者」全產業鏈生態。

AI醫療的核心是通過提升醫學證據質量與生成效率,優化研發、診斷及治療流程,最終實現更安全、更優質、更可及的醫療服務。醫渡科技持續提升醫療服務效率與可及性,讓醫生擁有更精準高效的決策工具,讓藥企縮短分子到患者距離,讓患者享有更可負擔的精準診斷和治療,讓公共系統獲得更科學的支撐。醫療AI的價值,體現在對每一個個體生命的尊重與對健康福祉的守護。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account